Interactive Brokers' Balanced Growth Is Beating the Rate-Cut Math
The bull/bear standoff here is well worn — an elite compounding franchise trading at roughly 40x earnings against a structural share-issuance overhang. That framing is the starting point, not the answer.
What tips the balance is the cadence of the underlying metrics: account, balance and volume growth are not just holding up against lower benchmark rates, they are accelerating into the summer, and a regulatory change just widened the retail funnel. The controlled-company supply overhang is real but economically neutral; it manufactures air pockets around prints and offerings that read as entries rather than thesis breaks.
What you are actually buying
Interactive Brokers is not a conventional discount broker. It is a vertically integrated, almost entirely automated execution-and-clearing machine that custodies assets for individuals, hedge funds, advisors, and introducing brokers across more than 170 venues in 40 countries. The economic engine has two cylinders: commissions on trading activity, and — larger — net interest income earned on the spread between what it charges on margin loans and what it pays (or doesn't) on the ballooning pile of customer cash. In 2025 the firm produced $6.2 billion of net revenue at a 77% pretax margin, a level that reflects a genuine cost structure advantage, not a cyclical peak. Headcount finished the year at just over 3,000 — a rounding error relative to the balances the platform now handles.
There is a governance wrinkle that matters to the thesis. The public entity, IBG, Inc., owns only about 26.3% of the operating company, IBG LLC; founder Thomas Peterffy and insiders hold the other ~73.7% through Holdings and control the voting power. Those interests get monetized over time by issuing new public shares — a permanent, pre-announced dilution mechanism. Hold that thought; it is the crux of the stock.
The shares recently changed hands near $95, valued at $94.93 with a market cap around $42 billion and a P/E of roughly 41 — call it 40x trailing earnings on ~$2.33 TTM EPS. That sits just shy of the $97.84 52-week high, well above the $56.33 low of the past year. This is a demanding multiple. The question is whether the operating trajectory earns it.
The flywheel is accelerating, not merely holding
Start with the first quarter, reported in April. Commission revenue rose 19% to $613 million on higher trading volumes, customer accounts increased 31% to 4.75 million, customer equity climbed 38% to $789.4 billion, and total DARTs grew 24% to 4.37 million. Crucially, the interest-earning balances that drive NII expanded even faster: customer credits increased 35% to $168.8 billion and customer margin loans increased 35% to $86.0 billion. Reported net revenue of $1.67 billion and pretax income of $1.29 billion held the pretax margin at roughly 77%. Diluted EPS was $0.59 ($0.60 adjusted), up from $0.48 a year earlier.
The tape did not celebrate — the print landed essentially in line and the stock slipped modestly — which is precisely the setup a patient buyer wants. Because the monthly disclosures since then show the flywheel spinning faster. May produced 4.969 million DARTs, up 47% year over year, ending client equity of $937.3 billion, and margin loans of $100.9 billion, up 65%. June extended it: accounts ended at 5.18 million, up 34%, with client equity of $930.3 billion, up 40% year over year, and June DARTs came in 53% higher than the prior year. Three inputs — accounts, balances, activity — are all compounding at once, and the sequential acceleration from the Q1 base is the most important tell heading into the July 21 report.
There is now a discrete regulatory tailwind on top of the organic growth. The Pattern Day Trader rule — the $25,000 minimum-equity wall that kept smaller active traders out of intraday margin trading for a quarter century — is gone. The SEC approved FINRA's amendments to Rule 4210 on April 14, 2026, eliminating the $25,000 requirement and the PDT designation entirely, with a June 4 effective date. The replacement is a risk-based intraday margin standard tied to a customer's actual market exposure through the day. This plays directly to IBKR's structural strength: the firm already runs real-time, automated margin calculation and liquidation across every product and currency, so the compliance lift is trivial while the addressable pool of active margin traders widens. It is a small, favorable nudge to engagement at exactly the margin where IBKR competes best.
Reframing the rate-cut fear
The reflexive worry is that a rate-cutting Fed guts NII. The near-term math says otherwise. Management's own sensitivity work pegs a 25-basis-point decline in U.S. dollar rates at roughly $77 million of annualized NII, plus about $31 million if all non-USD benchmarks fall in parallel — on the order of $100 million against a net interest income run-rate that exceeded $3.5 billion in 2025. That is a headwind, not a hole.
And it is being swamped by balances. Even with the average federal funds rate falling to 4.21% in 2025 from 5.14%, net interest income still grew 13% for the full year because margin loans, credit balances, and segregated assets grew faster than yields compressed — net interest margin slipped to 2.08% from 2.35%, yet the dollars went up. With margin loans running above $100 billion by mid-2026 versus roughly $69 billion average in 2025, the balance-growth offset is intact. Securities lending is the quiet contributor: as accounts and international breadth expand, so does the supply of lendable stock, and the total economics stay healthy even as the accounting shuttles income between "segregated cash" and "securities lending" lines depending on the rate regime. In short, rates are a second-order variable here; balances and volumes are first-order, and both are moving the right way.
The real bear case: supply and governance
This is where I part ways with the "just own the compounder" crowd — and also with the doomsayers. The credible risk is not the business; it is the share count. As a controlled company, IBKR has a standing mechanism to issue new stock to redeem Holdings interests, and the filings make clear such offerings are expected roughly annually and could be sizable — in July 2025 the company issued 3.836 million shares worth about $254 million, and over time the remaining ~1.25 billion Holdings units could convert into public float. Equity compensation adds a steady trickle; shareholders just approved a 10-year extension of the stock incentive plan.
Two points resolve this. First, the redemptions are largely economically neutral — IBG, Inc.'s ownership of IBG LLC rises proportionally as shares are issued, so book value per share is not diluted the way a naked secondary would be. Second, in a market this sensitive to supply and this rich on valuation, an offering announcement can still dent sentiment and knock the stock several percent regardless of the economics. That is the point: the overhang creates episodic, sentiment-driven pullbacks around offering windows and prints, not a deterioration in intrinsic value. Two steps up on fundamentals, one step back on issuance headlines. Those steps back are where the risk/reward improves.
IBKR keeps adding reasons for power users to consolidate activity on its platform, and the pace has picked up: a unified interface for trading prediction markets across Kalshi, CME Group and its own ForecastEx, agentic trading through a direct integration with Anthropic's Claude, the launch of select Korean equities through Nextrade, and smaller "nano" Bitcoin and Ether futures from Coinbase Derivatives that allow around-the-clock crypto exposure with less capital. None of these needs to be a material revenue line to matter; collectively they raise switching costs and reinforce the brand as the professional's broker.
The competitive psychology also favors IBKR. When peers push into prediction markets — Charles Schwab, for instance, is launching its own — it validates the category IBKR already serves while pressuring rivals' economics. IBKR's refusal to sell order flow for IBKR Pro remains a credible differentiator, and it already pays among the industry's most competitive rates on idle cash while preserving a clean spread — an edge that widens if rate cuts force low-deposit-beta competitors to raise client yields. The regulatory wildcards are honest risks: prediction-contract and third-party crypto-custody arrangements carry headline and counterparty exposure, and the SEC's proposal to scrap the Order Protection Rule could reshape best-execution dynamics. But these are defense-and-stickiness levers, not near-term P&L bets, and I value them accordingly.
Valuation and stance
At roughly 40x trailing and high-30s forward earnings, IBKR is priced for continued compounding — there is no valuation cushion if growth stalls. My resolution to the standoff is that the evidence base for near-term compounding is unusually deep and the logical chain short: accounts, DARTs, margin loans and client equity are all accelerating into the July 21 print; the PDT change widens the funnel; and balance growth is out-earning the rate-cut drag. Against that, the only structural offset — share issuance — is economically neutral and episodic.
The stance that follows is a constructive one: the bias is upward into second-quarter results, and the recurring, issuance-driven downdrafts are opportunities to add rather than reasons to exit. The board's increase of the quarterly dividend to $0.0875 per share is a minor sweetener; the story is operating leverage on a still-expanding base. I would treat any offering-related pullback as the better entry the tape occasionally hands out — not as a break in a thesis that the monthly numbers keep confirming.
Disclosure: This article is for informational purposes only. It does not constitute investment advice. Investors should conduct their own due diligence before making investment decisions.